Synektik

Synektik Interest Expense

The Interest Expense of Synektik (SNT.WA) as of Oct 31, 2026 is -1.58 M PLN. In the previous year, Interest Expense was -3.02 M PLN — a change of -47.73% (higher).

Interest Expense

-1.58 MPLN

YoY

-47.73%

Last updated:

Interest Expense of Synektik is 2025 -1.58 M PLN. Interest Expense of Synektik was 2024 -3.02 M PLN. It decreases by -47.73% higher compared to the previous year.

The Synektik Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2018
-919,100.00 PLN
Jan 1, 2019
-948,000.00 PLN
Jan 1, 2020
-938,300.00 PLN
Jan 1, 2021
-316,200.00 PLN
Jan 1, 2022
-6.41 M PLN
Jan 1, 2023
-1.67 M PLN
Jan 1, 2024
-3.02 M PLN
Jan 1, 2025
-1.58 M PLN
The Synektik Interest Expense history
YEARInterest ExpenseYoY
-1.58 MPLN-47.73%
-3.02 MPLN+81.52%
-1.67 MPLN-74.02%
-6.41 MPLN+1,927.23%
-316,200.00PLN-66.30%
-938,300.00PLN-1.02%
-948,000.00PLN+3.14%
-919,100.00PLN+162.60%
-350,000.00PLN+99.09%
-175,800.00PLN-71.26%
-611,600.00PLN+51.61%
-403,400.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

Interest Expense of Synektik is -1.58 M PLN in 2025.

Interest Expense of Synektik changed from -3.02 M PLN to -1.58 M PLN, representing a -47.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Synektik since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Synektik historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Synektik

All Key Metrics — Synektik